OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 ...

Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Pharma industry loses on Medicare price ...

This piece is the first in a series exploring the foundational players in the U.S. healthcare system: payers, providers, ...

Collegium Pharmaceutical earns the No. 2 rank among its peers in the Medical-Generic Drugs industry group. ANI ...

Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...

The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 ...

President Trump has imposed a 15 percent tariff on most items in a trade agreement with the European Union, with ...

And pharmaceutical companies spend big on lobbying in Washington — more than any other industry in 2017 — helping to assure victories like the 2003 Medicare Part D legislation which banned the ...

ZEYNEP TUFEKCI: The pharmaceutical industry heads into Musk's wood chipper Wednesday, Feb. 12, 2025 -- The National Institutes of Health would slash funding for medical research doesn't make even ...

BNP Secretary General Mirza Fakhrul Islam Alamgir has warned of a severe crisis in the pharmaceutical industry, alleging that ...

The pharmaceutical sector, a beacon of innovation, stands tall in Europe's economic landscape. Yet even a robust industry is not immune to financial challenges.